JAK1 and Hepatic fibrosis: The recent identification of PZH’s modulation of the EGFR/JAK1/STAT3 pathway enhances its known inhibitory effects on the TGF-β1/Smad2 axis, thereby elucidating a multifaceted mechanism against hepatic fibrosis.